{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:00:11Z","timestamp":1780938011081,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,8]]},"DOI":"10.7759\/cureus.110468","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:20:49Z","timestamp":1780935649000},"source":"Crossref","is-referenced-by-count":0,"title":["Refractory Malignant Pericardial Effusion as the Initial Presentation of Early T-Cell Precursor Acute Lymphoblastic Leukemia\/Lymphoma"],"prefix":"10.7759","author":[{"given":"Ahmad","family":"Jalil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Willans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Kandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Varshitha","family":"Bandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith E","year":"2009","unstructured":"Coustan-Smith E, Mullighan CG, Onciu M, et al.. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009, 10:147-56. 10.1016\/S1470-2045(08)70314-0","journal-title":"Lancet Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.580","article-title":"T-cell acute lymphoblastic leukemia","volume":"2016","author":"Raetz EA","year":"2016","unstructured":"Raetz EA, Teachey DT. T-cell acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2016, 2016:580-8. 10.1182\/asheducation-2016.1.580","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24946","article-title":"Characteristics of pericardial effusions in patients with leukemia","volume":"116","author":"Sampat K","year":"2010","unstructured":"Sampat K, Rossi A, Garcia-Gutierrez V, Cortes J, Pierce S, Kantarjian H, Garcia-Manero G. Characteristics of pericardial effusions in patients with leukemia. Cancer. 2010, 116:2366-71. 10.1002\/cncr.24946","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/dc.24197","article-title":"The value of cytology in diagnosis of serous effusions in malignant lymphomas: An experience of a tertiary care center","volume":"47","author":"Patel T","year":"2019","unstructured":"Patel T, Patel P, Mehta S, Shah M, Jetly D, Khanna N. The value of cytology in diagnosis of serous effusions in malignant lymphomas: An experience of a tertiary care center. Diagn Cytopathol. 2019, 47:776-82. 10.1002\/dc.24197","journal-title":"Diagn Cytopathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/dc.24772","article-title":"Cytomorphology, immunophenotype, and cytogenetic profile of leukemic serous effusions","volume":"49","author":"Kaur K","year":"2021","unstructured":"Kaur K, Patel T, Patra S, Trivedi P. Cytomorphology, immunophenotype, and cytogenetic profile of leukemic serous effusions. Diagn Cytopathol. 2021, 49:948-58. 10.1002\/dc.24772","journal-title":"Diagn Cytopathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21584","article-title":"Precursor T-lymphoblastic lymphoma: speedy diagnosis in FNA and effusion cytology by morphology, immunochemistry, and flow cytometry","volume":"123","author":"Bhaker P","year":"2015","unstructured":"Bhaker P, Das A, Rajwanshi A, et al.. Precursor T-lymphoblastic lymphoma: speedy diagnosis in FNA and effusion cytology by morphology, immunochemistry, and flow cytometry. Cancer Cytopathol. 2015, 123:557-65. 10.1002\/cncy.21584","journal-title":"Cancer Cytopathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16203466","article-title":"Pericardial disease in patients with cancer: clinical insights on diagnosis and treatment","volume":"16","author":"Lorenzo-Esteller L","year":"2024","unstructured":"Lorenzo-Esteller L, Ramos-Polo R, Pons Riverola A, et al.. Pericardial disease in patients with cancer: clinical insights on diagnosis and treatment. Cancers (Basel). 2024, 16:3466. 10.3390\/cancers16203466","journal-title":"Cancers (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2024.04.010","article-title":"Pericardial diseases: international position statement on new concepts and\u00a0advances in multimodality cardiac imaging","volume":"17","author":"Klein AL","year":"2024","unstructured":"Klein AL, Wang TK, Cremer PC, et al.. Pericardial diseases: international position statement on new concepts and\u00a0advances in multimodality cardiac imaging. JACC Cardiovasc Imaging. 2024, 17:937-88. 10.1016\/j.jcmg.2024.04.010","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.00.745","article-title":"Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion","volume":"23","author":"Gornik HL","year":"2005","unstructured":"Gornik HL, Gerhard-Herman M, Beckman JA. Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol. 2005, 23:5211-6. 10.1200\/JCO.2005.00.745","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2010.42.4.210","article-title":"Clinical characteristics of malignant pericardial effusion associated with recurrence and survival","volume":"42","author":"Kim SH","year":"2010","unstructured":"Kim SH, Kwak MH, Park S, et al.. Clinical characteristics of malignant pericardial effusion associated with recurrence and survival. Cancer Res Treat. 2010, 42:210-6. 10.4143\/crt.2010.42.4.210","journal-title":"Cancer Res Treat"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.805981","article-title":"Cardiac infiltration as the first manifestation of acute lymphoblastic leukemia: a systematic review","volume":"12","author":"Luo Z","year":"2022","unstructured":"Luo Z, Cheng J, Wang Y. Cardiac infiltration as the first manifestation of acute lymphoblastic leukemia: a systematic review. Front Oncol. 2022, 12:805981. 10.3389\/fonc.2022.805981","journal-title":"Front Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.08006.x","article-title":"Paediatric lymphoblastic T-cell leukaemia and lymphoma: one or two diseases?","volume":"149","author":"Burkhardt B","year":"2010","unstructured":"Burkhardt B. Paediatric lymphoblastic T-cell leukaemia and lymphoma: one or two diseases?. Br J Haematol. 2010, 149:653-68. 10.1111\/j.1365-2141.2009.08006.x","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4428","article-title":"Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma","volume":"104","author":"Thomas DA","year":"2004","unstructured":"Thomas DA, O'Brien S, Cortes J, et al.. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood. 2004, 104:1624-30. 10.1182\/blood-2003-12-4428","journal-title":"Blood"},{"key":"ref14","article-title":"Venetoclax plus azacitidine in relapsed or refractory T-cell acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 trial","volume":"1200284","author":"Cao HY","year":"2025","unstructured":"Cao HY, Zhang H, Zhang Y, et al.. Venetoclax plus azacitidine in relapsed or refractory T-cell acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 trial. Lancet Haematol. 2025, 1200284:4.","journal-title":"Lancet Haematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000002672","article-title":"Short-course venetoclax with standard chemotherapy is effective in early T-cell precursor acute lymphoblastic leukemia","volume":"45","author":"Borah P","year":"2023","unstructured":"Borah P, Dayal N, Pathak S, Naithani R. Short-course venetoclax with standard chemotherapy is effective in early T-cell precursor acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2023, 45:271-4. 10.1097\/MPH.0000000000002672","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/496431-refractory-malignant-pericardial-effusion-as-the-initial-presentation-of-early-t-cell-precursor-acute-lymphoblastic-leukemialymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:20:49Z","timestamp":1780935649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/496431-refractory-malignant-pericardial-effusion-as-the-initial-presentation-of-early-t-cell-precursor-acute-lymphoblastic-leukemialymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.110468","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,8]]}}}